Patents by Inventor K. C. Sung

K. C. Sung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • KINASE INHIBITOR SALTS AND COMPOSITIONS THEREOF
    Publication number: 20230142737
    Abstract: The present invention relates to cabozantinib lauryl sulfate salt and methods of use.
    Type: Application
    Filed: January 13, 2023
    Publication date: May 11, 2023
    Applicant: Handa Oncology, LLC
    Inventors: FANG-YU LIU, K. C. SUNG, CHIN-YAO YANG, CHI-CHENG LIN, YI-HSIN LIN, LI QIAO
  • Kinase inhibitor salts and compositions thereof
    Patent number: 11160805
    Abstract: The present invention relates to kinase inhibitor C8-C16 aliphatic sulfate salts, compositions containing kinase inhibitor C8-C16 aliphatic sulfate salts and uses thereof.
    Type: Grant
    Filed: February 24, 2020
    Date of Patent: November 2, 2021
    Assignee: HANDA ONOCOLOGY, LLC
    Inventors: Fang-Yu Liu, K. C. Sung, Chin-Yao Yang, Chi-Cheng Lin, Yi-Hsin Lin, Li Qiao
  • KINASE INHIBITOR SALTS AND COMPOSITIONS THEREOF
    Publication number: 20210283133
    Abstract: The present invention relates to capsules comprising dasatinib lauryl sulfate salt.
    Type: Application
    Filed: May 17, 2021
    Publication date: September 16, 2021
    Applicant: HANDA ONCOLOGY, LLC
    Inventors: FANG-YU LIU, K.C. SUNG, CHIN-YAO YANG, CHI-CHENG LIN, YI-HSIN LIN, LI QIAO
  • Kinase inhibitor salts, and compositions thereof
    Patent number: 11052088
    Abstract: The present invention relates to polymorphic forms of dasatinib lauryl sulfate salt.
    Type: Grant
    Filed: February 4, 2021
    Date of Patent: July 6, 2021
    Assignee: Handa Oncology, LLC
    Inventors: Fang-Yu Liu, K. C. Sung, Chin-Yao Yang, Chi-Cheng Lin, Yi-Hsin Lin, Li Qiao
  • KINASE INHIBITOR SALTS, AND COMPOSITIONS THEREOF
    Publication number: 20210161895
    Abstract: The present invention relates to polymorphic forms of dasatinib lauryl sulfate salt.
    Type: Application
    Filed: February 4, 2021
    Publication date: June 3, 2021
    Applicant: Handa Oncology, LLC
    Inventors: FANG-YU LIU, K.C. SUNG, CHIN-YAO YANG, CHI-CHENG LIN, YI-HSIN LIN, LI QIAO
  • Kinase inhibitor salts, and compositions thereof
    Patent number: 11007195
    Abstract: The present invention relates to kinase inhibitor C8-C16 aliphatic sulfate salts, compositions containing kinase inhibitor C8-C16 aliphatic sulfate salts and uses thereof.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: May 18, 2021
    Assignee: HANDA ONCOLOGY, LLC
    Inventors: Fang-Yu Liu, K.C. Sung, Chin-Yao Yang, Chi-Cheng Lin, Yi-Hsin Lin, Li Qiao
  • Kinase inhibitor salts and compositions thereof
    Patent number: 10940149
    Abstract: The present invention relates to polymorphic forms of nilotinib lauryl sulfate salt.
    Type: Grant
    Filed: October 30, 2020
    Date of Patent: March 9, 2021
    Assignee: HANDA ONCOLOGY, LLC
    Inventors: Fang-Yu Liu, K. C. Sung, Chin-Yao Yang, Chi-Cheng Lin, Yi-Hsin Lin, Li Qiao
  • KINASE INHIBITOR SALTS AND COMPOSITIONS THEREOF
    Publication number: 20210046077
    Abstract: The present invention relates to polymorphic forms of nilotinib lauryl sulfate salt.
    Type: Application
    Filed: October 30, 2020
    Publication date: February 18, 2021
    Applicant: HANDA PHARMACEUTICALS, LLC
    Inventors: FANG-YU LIU, K.C. SUNG, CHIN-YAO YANG, CHI-CHENG LIN, YI-HSIN LIN, LI QIAO
  • KINASE INHIBITOR SALTS AND COMPOSITIONS THEREOF
    Publication number: 20200188400
    Abstract: The present invention relates to kinase inhibitor C8-C16 aliphatic sulfate salts, compositions containing kinase inhibitor C8-C16 aliphatic sulfate salts and uses thereof.
    Type: Application
    Filed: February 24, 2020
    Publication date: June 18, 2020
    Applicant: HANDA PHARMACEUTICALS, LLC
    Inventors: FANG-YU LIU, K.C. SUNG, CHIN-YAO YANG, CHI-CHENG LIN, YI-HSIN LIN, LI QIAO
  • KINASE INHIBITOR SALTS, AND COMPOSITIONS THEREOF
    Publication number: 20200113903
    Abstract: The present invention relates to kinase inhibitor C8-C16 aliphatic sulfate salts, compositions containing kinase inhibitor C8-C16 aliphatic sulfate salts and uses thereof.
    Type: Application
    Filed: December 3, 2019
    Publication date: April 16, 2020
    Applicant: HANDA PHARMACEUTICALS, LLC
    Inventors: FANG-YU LIU, K.C. SUNG, CHIN-YAO YANG, CHI-CHENG LIN, YI-HSIN LIN, LI QIAO
  • Release stable mesalamine dosage forms
    Patent number: 10098898
    Abstract: Solid oral mesalamine delayed/controlled release tablets with storage stable dissolution profiles are described.
    Type: Grant
    Filed: December 4, 2017
    Date of Patent: October 16, 2018
    Assignee: HANDA PHARMACEUTICALS, LLC
    Inventors: K. C. Sung, Chi-Cheng Lin, Chin-Yao Yang, Fang-Yu Liu
  • Method and system for resetting a subsystem of a communication device
    Patent number: 8495422
    Abstract: Described herein are a method, system, and computer readable medium for resetting a subsystem of a communication device. The method involves utilizing a subsystem error handler to generate a reset request signal indicating the subsystem has experienced an exception; distributing to a software component, residing externally to the subsystem, a status message indicative of a current state of the subsystem; performing a reset of the subsystem in response to the reset request signal; and rebooting the subsystem. When the subsystem can be reset without performing a system wide reset of the communication device, communication device downtime is reduced, which facilitates a positive user experience.
    Type: Grant
    Filed: June 11, 2010
    Date of Patent: July 23, 2013
    Assignee: Research In Motion Limited
    Inventors: Evgeny Mezhibovsky, Joseph Tu-Long Deu-Ngoc, Alan K. C. Sung, Jeffrey P. Laver, Anthony W. Tod
  • METHOD AND SYSTEM FOR RESETTING A SUBSYSTEM OF A COMMUNICATION DEVICE
    Publication number: 20110202797
    Abstract: Described herein are a method, system, and computer readable medium for resetting a subsystem of a communication device. The method involves utilizing a subsystem error handler to generate a reset request signal indicating the subsystem has experienced an exception; distributing to a software component, residing externally to the subsystem, a status message indicative of a current state of the subsystem; performing a reset of the subsystem in response to the reset request signal; and rebooting the subsystem. When the subsystem can be reset without performing a system wide reset of the communication device, communication device downtime is reduced, which facilitates a positive user experience.
    Type: Application
    Filed: June 11, 2010
    Publication date: August 18, 2011
    Inventors: Evgeny Mezhibovsky, Joseph Tu-Long Deu-Ngoc, Alan K.C. Sung, Jeffrey P. Laver, Anthony W. Tod